This post was originally published on this site
Pfizer announced earnings per share of $1.34 on revenue of $24.09B. Analysts polled by Investing.com anticipated EPS of $1.08 on revenue of $22.56B.
Pfizer shares are up 18% from the beginning of the year, still down 15.85% from its 52 week high of $51.86 set on August 18. They are under-performing the S&P Global 100 which is up 19.28% from the start of the year.
Pfizer’s report follows an earnings beat by J&J on October 19, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.35 on revenue of $23.64B.
Thermo Fisher Scientific had beat expectations on October 27 with third quarter EPS of $5.76 on revenue of $9.33B, compared to forecast for EPS of $4.68 on revenue of $8.38B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
